Imaging Tumor Function and Response with Optoacoustics

April 2, 2020
Dr. Katja Haedicke, iThera Medical
YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Poor spatial resolution of current imaging modalities often limits monitoring of both angiogenesis and outcome of vascular-targeted therapies. So far, a detailed evaluation has only been possible using invasive approaches. RSOM (raster-scanning optoacoustic mesoscopy) takes advantage of the intrinsic optical properties of hemoglobin, high-frequency laser illumination, and detection of a broad ultrasound bandwidth. This provides non-invasive, high-resolution images of differentsized tumor vessels and facilitates detailed insights into dynamic responses to novel vascular-targeted therapies.

Contact us

If you have any questions about our technology, applications or products, don’t hesitate to get in touch.